INNV InnovAge
InnovAge earnings company data as of 11:02 AM ET 10/23
- 0 of 1 EPS beats
History
2 periods, newest first. Each row shows EPS above revenue.
| Period | Date | Metric | Estimate | Actual | Result |
|---|---|---|---|---|---|
| FY2026 Q3 | 3 Nov | EPS | 0.12 | — | — |
| Rev | — | — | — | ||
| FY2026 Q4 | 8 Sep | EPS | 0.08 | -0.01 | Miss |
| Rev | $253.4M | $262.0M | Beat +3.4% |
Insider trades
Open-market buys and sales by INNV's executives, directors and 10% owners in the last 12 months, from their Form 4s
- None no insider bought on the open market
- $185M sold by 4 insiders outside a trading plan
- $207K sold by 1 insider under 10b5-1 plans
-
Nicole Damato Chief Legal OfficerPlanned sale$207K 23,814 shares at $8.70 7.2% of stakeTraded Sep 25 Filed Sep 29
-
Tco Group Holdings, L.P. 10% ownerSale$92.5M 10M shares at $9.25 8.9% of stakeTraded Sep 24 Filed Sep 28
-
Welsh, Carson, Anderson & Stowe XII, L.P. 10% owner, +9 joint filersSale— 10M shares 8.9% of stakeTraded Sep 24 Filed Sep 28
-
Michael Anthony Scarbrough COOSale$162K 33,000 shares at $4.90 22% of stakeTraded Nov 14, 2025 Filed Nov 17, 2025
Also filed in the last 12 months, not counted as buying or selling: 12 stock grants, 7 share withholdings for taxes, and 3 other transactions.
SEC filings
Recent issuer filings from EDGAR, 17 shown.
| Filed | Form | Detail | Links |
|---|---|---|---|
| DEF 14A | Filing Doc | ||
| DEFA14A | Filing Doc | ||
| 8-K | 8.01,9.01 | Filing Doc | |
| 424B4 | Filing Doc | ||
| 424B7 | Filing Doc | ||
| 10-K | Filing Doc | ||
| 8-K | 2.02,9.01 | Filing Doc | |
| 8-K | 7.01 | Filing Doc | |
| 8-K | 5.02,7.01,9.01 | Filing Doc | |
| 10-Q | Filing Doc | ||
| 8-K | 2.02,9.01 | Filing Doc | |
| 8-K | 7.01 | Filing Doc | |
| 8-K | 2.02,9.01 | Filing Doc | |
| 10-Q | Filing Doc | ||
| 8-K | 5.02,7.01,9.01 | Filing Doc | |
| 8-K | 7.01,9.01 | Filing Doc | |
| 8-K | 5.07 | Filing Doc |
No filings match this filter.
Estimates are consensus figures; SEC filings remain the official record. Not investment advice.